# PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
> **ANDA202217** · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2014-08-20
## Drug
- **FDA Application Number:** ANDA202217
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
- **Generic name:** POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET
- **Active ingredients:** BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- **Dosage form:** FOR SOLUTION, TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVEL LABS INC
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2014-08-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202217)
---
*MORVS · CC0 1.0*